--%>

ICGI Articles

  • Complex Genetic Evolution and Treatment Challenges in Myeloid Neoplasms: A Case of Persistent t(2;3)(p15~23;q26)/MECOM Rearrangement, SF3B1 Mutation, and Transient TNIP1::PDGFRB Chimera

    Published: 21.01.2025

    Andersen K, Tjønnfjord GE, Hestdalen ML, Spetalen S, Panagopoulos I

    Cancer Genomics Proteomics, 22 (1), 24-33

    PubMed 39730178

  • Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapy

    Published: 23.11.2024

    Behsen AD, Holien T, Micci F, Rye M, Malm Rasmussen J, Andersen K, Svorkdal Hess E, Børset M, Keats J, Våtsveen TK, Misund K

    Sci Rep. 2024 Nov 20;14(1):28805.

    PubMed 39567630

  • Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer

    Published: 14.11.2024

    Kleppe A, Lindemann K, Kildal W, Tobin KAR, Pradhan M, Vlatcovic L, Isaksen M, Danielsen HE, Askautrud HA, Kristensen GB

    Gynecol Oncol. 2024 Nov 15:192:80-88

    PubMed 39549540

  • Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)

    Published: 25.09.2024

    Brunetti M, Andersen K, Trøen G, Micci F, Spetalen S, Lenartova A, Tandsæther MR, Panagopoulos I

    Front Oncol. 2024 Sep 26:14:1428984.

    PubMed 39391249

  • RUNX1::MIR99AHG Chimera in Acute Myeloid Leukemia

    Published: 23.09.2024

    Andersen K, Tjønnfjord GE, Ramslien LF, Panagopoulos I

    Genes Chromosomes Cancer, 63 (9), e23272

    PubMed 39324493

  • DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance

    Published: 14.09.2024

    Cyll K, Skaaheim Haug E, Pradhan M, Vlatkovic L, Carlsen B, Löffeler S, Kildal W, Skogstad K, Hauge Torkelsen F, Syvertsen RA, Askautrud HA, Liestøl K, Kleppe A, Danielsen HE

    Br J Cancer, 131 (5), 895-904

    PubMed 38961192

  • Genetic Heterogeneity in Cellular Angiofibromas

    Published: 19.08.2024

    Panagopoulos I, Andersen K, Lobmaier I, Lund-Iversen M

    Genes Chromosomes Cancer, 63 (8), e23262

    PubMed 39120141

  • Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome

    Published: 22.07.2024

    Heggebø LC, Blakstad H, Eriksson MC, Brandal P

    BMJ Case Rep. 2024 Jul 23;17(7):e260450

    PubMed 39043464

  • 3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas

    Published: 15.07.2024

    Tabouret E, Furtner J, Graillon T, Silvani A, Le Ruhn E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszuz M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M

    Neuro Oncol . 2024 Jul 5;26(7):1302-1309

    PubMed 38452246

  • Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes

    Published: 14.07.2024

    Kildal W, Cyll K, Kalsnes J, Islam R, Julbø FM, Pradhan M, Ersvær E, Shepherd N, Vlatkovic L, OSBREAC, Tekpli X, Garred Ø, Kristensen GB, Askautrud HA, Hveem TS, Danielsen HE, OSBREAC - Oslo Breast Cancer Consortium (2024)

    Heliyon. 2024 Jul 15; 10(13): e32529.

    PubMed 39040241

  • « 1 2 3 4 5  ... Previous Next » 

Chief Editor: Tarjei S. Hveem, Interim Institute Director
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20